Article Details
Retrieved on: 2019-04-17 23:56:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>As of 2018 Q4 <b>Benchmark Capital</b> Advisors has 0.76% invested in Galectin Therapeutics Inc. Galectin Therapeutics Inc's shareholder Cutter & Co ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here